Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|January 1, 1991
Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemiaJ Drach, C Gattringer, H Huber
Clinical and Experimental Immunology|March 1, 1991
Expression of the neural cell adhesion molecule (CD56) by human myeloma cellsJ Drach, C Gattringer, H Huber
British Journal of Haematology|June 1, 1995
Low incidence of MDR1 expression in acute promyelocytic leukaemiaD Drach, S Zhao, J Drach, et al.
Biochemical and Biophysical Research Communications|March 16, 1992
Proliferation of hematopoietic cells is accompanied by suppressed expression of heat shock protein 70W Zhang, J Drach, M Andreeff, et al.
Biochemical and Biophysical Research Communications|September 15, 1993
Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acidJ Drach, S Zhao, F Malavasi, et al.
Oncology|October 2, 2013
Bortezomib administered subcutaneously is well tolerated in bortezomib-based combination regimens used in patients with multiple myelomaW Lamm, B Drach-Schauer, S Eder, et al.
Leukemia Research|May 1, 1993
Flow cytometric detection of cytoplasmic antigens in acute leukemias: implications for lineage assignmentD Drach, J Drach, H Glassl, et al.
Onkologie|February 1, 1989
GM-CSF treatment in aplasia after cytotoxic therapyC Gattringer, J Thaler, J Drach, et al.
Annals of Hematology|September 21, 2001
Advances in the biology and therapeutic management of multiple myelomaH Kaufmann, E Urbauer, J Ackermann, et al.
Cytometry|January 1, 1992
Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual diseaseJ Drach, D Drach, H Glassl, et al.
Pageof 8